v1
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901.
- NobleID
- NI4P16W94R37S86
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/F2BA24B7
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims